These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 21888425

  • 1. Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop.
    Andrianov AM, Anishchenko IV, Tuzikov AV.
    J Chem Inf Model; 2011 Oct 24; 51(10):2760-7. PubMed ID: 21888425
    [Abstract] [Full Text] [Related]

  • 2. Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.
    Andrianov AM, Kornoushenko YV, Anishchenko IV, Eremin VF, Tuzikov AV.
    J Biomol Struct Dyn; 2013 Oct 24; 31(7):665-83. PubMed ID: 22888999
    [Abstract] [Full Text] [Related]

  • 3. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
    Andrianov AM, Anishchenko IV.
    J Biomol Struct Dyn; 2009 Oct 24; 27(2):179-93. PubMed ID: 19583444
    [Abstract] [Full Text] [Related]

  • 4. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
    Andrianov AM, Veresov VG.
    J Biomol Struct Dyn; 2007 Jun 24; 24(6):597-608. PubMed ID: 17508782
    [Abstract] [Full Text] [Related]

  • 5. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM, Kornoushenko YV, Kashyn IA, Kisel MA, Tuzikov AV.
    J Biomol Struct Dyn; 2015 Jun 24; 33(5):1051-66. PubMed ID: 24942968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD.
    Biochemistry; 1996 Apr 23; 35(16):5158-65. PubMed ID: 8611499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 14. Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches.
    Andrianov AM, Veresov VG.
    Biochemistry (Mosc); 2006 Aug 10; 71(8):906-14. PubMed ID: 16978155
    [Abstract] [Full Text] [Related]

  • 15. Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.
    Andrianov AM.
    J Biomol Struct Dyn; 2008 Oct 10; 26(2):247-54. PubMed ID: 18597546
    [Abstract] [Full Text] [Related]

  • 16. Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study.
    Andrianov AM, Kashyn IA, Tuzikov AV.
    J Biomol Struct Dyn; 2014 Dec 10; 32(12):1993-2004. PubMed ID: 24251545
    [Abstract] [Full Text] [Related]

  • 17. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
    Ebenbichler C, Westervelt P, Carrillo A, Henkel T, Johnson D, Ratner L.
    AIDS; 1993 May 10; 7(5):639-46. PubMed ID: 7686374
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.